Search results
Search for "ocular drug delivery" in Full Text gives 2 result(s) in Beilstein Journal of Nanotechnology.
Recent advances in photothermal nanomaterials for ophthalmic applications
Beilstein J. Nanotechnol. 2025, 16, 195–215, doi:10.3762/bjnano.16.16
- neuropathy [125][126]. Currently, ocular drug delivery is the prevalent treatment approach; however, it faces challenges due to drug degradation and obstacles in drug diffusion, rendering the therapy less effective [127][128]. Therefore, ocular drug delivery systems capable of controlled and sustained drug
- penetration and deposition [163]. Moreover, common ocular drug delivery methods have disadvantages such as short intraocular retention time, low drug accumulation, and low bioavailability [164]. Because of the transparency of the cornea and crystalline lens, the eye allows various wavelengths of light to
Microneedle-based ocular drug delivery systems – recent advances and challenges
Beilstein J. Nanotechnol. 2022, 13, 1167–1184, doi:10.3762/bjnano.13.98
- physiology of the eye are summarized and discussed. Keywords: eye; microneedles; ocular drug delivery; ophthalmic drugs; Review 1 Introduction Since its first appearance in biomedicine, microtechnology is rapidly entering the world of pharmaceutical sciences, including pharmaceutical technology [1][2][3][4
- , research is focused on microneedle systems/patches for ocular drug delivery. Initially, such arrays were considered as painless, non-invasive, and highly efficient alternative for transdermal, intradermal, and percutaneous delivery of drugs [8][101][102]. Recently, it has been found that they can be
- microneedle coating are depicted in Figure 3 [171]. 3 An overview of microneedle systems for ocular drug delivery Considering the construction and the mechanism of action, four types of MNs used to deliver a drug to the eye can be distinguished in the scientific literature: (i) Solid MNs, used mostly for
Other Beilstein-Institut Open Science Activities
